Altimmune (NASDAQ:ALT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Altimmune (ALT) operate in?

Altimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Altimmune Stock (NASDAQ: ALT) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	473.00 / 3.32M
Day Range	- - -
52 Wk Range	2.09 - 14.84
Market Cap	$554.35M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	62
Short Interest	31.04%
Days to Cover	9.82

Recent News

Why Are Altimmune Shares Trading Lower Wednesday?

Altimmune shares are experiencing significant movement lower following the unexpected passing of Richard Eisenstadt, the company's Chief Financial Officer.

Vaishali Prayag

Altimmune Stock Is Rising Monday: What's Driving The Action?

Altimmune said it presented data from the 48-week Phase 2 MOMENTUM clinical trial of pemvidutide, including the results of a recently completed body composition analysis at the American Diabetes Association's 84th Scientific Sessions. Subjects in the pemvidutide groups had an average lean mass loss of 21.9% with 78.1% of weight loss attributable to fat.

Adam Eckert

RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Jun

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Altimmune Inc

Sector

Health Care

Industry

Biotechnology

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipe...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Altimmune (ALT) stock?

You can purchase shares of Altimmune (NASDAQ:ALT) through any online brokerage.

View our list of the best stock brokerages

Who are Altimmune (ALT) competitors?

Other companies in Altimmune’s space includes: KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC), Sage Therapeutics (NASDAQ:SAGE), Pharming (NASDAQ:PHAR) and Fate Therapeutics (NASDAQ:FATE).

What is the forecast, or price target, for Altimmune (ALT) stock?

Altimmune has a consensus price target of $22.00.

What is the current price for Altimmune (ALT)?

The stock price for Altimmune (NASDAQ: ALT) is $7.8 last updated September 19, 2024 at 4:23 AM EDT.

Does Altimmune (ALT) pay a dividend?

There are no upcoming dividends for Altimmune.

When is Altimmune (NASDAQ:ALT) reporting earnings?

Altimmune’s Q3 earnings are confirmed for Tuesday, November 5, 2024.

Is Altimmune (ALT) going to split?

There is no upcoming split for Altimmune.

What sector and industry does Altimmune (ALT) operate in?

Altimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now